招商輪船(601872.SH):香港明華擬訂造4艘6.2萬噸多用途船
格隆匯3月27日丨招商輪船(601872.SH)公佈,公司全資子公司香港明華船務有限公司(下稱“香港明華”)擬與關聯方招商局金陵船舶(南京)有限公司(下稱“金陵船廠”)就訂造4艘6.2萬噸多用途船簽署造船協議,建造價格不超過2967.4萬美元/艘(含佣金),總投資不超過1.19億美元,交船時間預計為2022年。
此次多用途船的購建計劃是公司散貨隊運力更新的需要。有利於提升散雜貨特色航線運營能力和經濟效益,穩定和提高對市場的控制能力。新造船交付後,將對優化公司散貨船隊結構,增強市場競爭力具有積極意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.